Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease

By sjmartinez • October 21, 2022

Nee R, Yuan CM, Narva AS, Yan G, Norris KC. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease. Nephrol Dial Transplant. 2022 Oct 20:gfac283. doi: 10.1093/ndt/gfac283. Epub ahead of print. PMID: 36264305.

Tags: cardiovascular disease, Chronic kidney disease, diabetes mellitus, glucagon-like peptide-1 receptor agonist, Nephrology, nonsteroidal mineralocorticoid receptor antagonist, Publications, sodium-glucose cotransporter-2 inhibitor

Exploring Nanofiltration for Transport of Small Molecular Species for Application in Artificial Kidney Devices to Treat End-Stage Kidney Disease

Duncan H, Newton C, Hestekin J, Hestekin C, Kurtz I. Exploring Nanofiltration for Transport of Small Molecular Species for Application in Artificial Kidney Devices to[...]

Managing the failing renal allograft: navigating a complex topography

Kendrick EA. Managing the failing renal allograft: navigating a complex topography. Front Nephrol. 2025 Jun 5;4:1223114. doi: 10.3389/fneph.2024.1223114. PMID: 40538581; PMCID: PMC12176546.

C3 glomerulopathy post kidney transplantation: A single center experience

Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL. C3 glomerulopathy post kidney transplantation: A single center experience.[...]